https://www.selleckchem.com/products/mtx-211.html
To assess whether the effectiveness of thermal ablation (TA) and stereotactic body radiotherapy (SBRT) as initial treatment for stage I lung cancer vary depending on the histological subtype. The 2004-2016 National Cancer Database was queried for patients with American Joint Committee on Cancer (AJCC) stage I lung cancer treated with TA or SBRT. Patients 18 yo, those treated with surgery or chemotherapy, or with unknown survival and follow-up were excluded. TA and SBRT patients were 15 propensity score matched separately for each h